Skip to main content

JMF, NHGRI to Develop Newborn Screening Tests on Affy Platform

NEW YORK, Oct. 5 (GenomeWeb News) - The Jeffrey Modell Foundation, a nonprofit devoted to researching pediatric immunodeficiency disorders, and the National Human Genome Research Institute intend to co-develop a post-natal screen for primary immunodeficiency based on Affymetrix's microarray platform, the three partners said today.

NHGRI will take the lead in developing the test, which will look for a form of DNA that is found in children with healthy immune systems. If the test results are unusual, a second test based on Affy's platform will screen for specific biomarkers associated with immunodeficiency.

JMF will fund the project. A time table for when the tests would become available was not discussed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.